Detalhe da pesquisa
1.
BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors.
Mol Cancer
; 22(1): 110, 2023 07 13.
Artigo
Inglês
| MEDLINE | ID: mdl-37443114
2.
Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain.
BMC Pulm Med
; 23(1): 69, 2023 Feb 21.
Artigo
Inglês
| MEDLINE | ID: mdl-36809990
3.
The integration of systemic and tumor PD-L1 as a predictive biomarker of clinical outcomes in patients with advanced NSCLC treated with PD-(L)1blockade agents.
Cancer Immunol Immunother
; 71(8): 1823-1835, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-34984538
4.
Association between Changes in the Patterns of Antinuclear Autoantibodies during Immune Checkpoint Inhibition Therapy and the Development of Severe Immune Related Adverse Events.
Int J Mol Sci
; 23(20)2022 Oct 20.
Artigo
Inglês
| MEDLINE | ID: mdl-36293498
5.
Circulating leukocyte-platelet complexes as a predictive biomarker for the development of immune-related adverse events in advanced non-small cell lung cancer patients receiving anti-PD-(L)1 blocking agents.
Cancer Immunol Immunother
; 70(6): 1691-1704, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-33388994
6.
Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based Platform.
Clin Chem
; 67(3): 554-563, 2021 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33439966
7.
Prognostic effect of VEGF gene variants in metastatic non-small-cell lung cancer patients.
Angiogenesis
; 22(3): 433-440, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30977010
8.
Pharmacogenetic clinical randomised phase II trial to evaluate the efficacy and safety of FOLFIRI with high-dose irinotecan (HD-FOLFIRI) in metastatic colorectal cancer patients according to their UGT1A 1 genotype.
Br J Cancer
; 120(2): 190-195, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30585257
9.
Genetic variants in the VEGF pathway as prognostic factors in stages II and III colon cancer.
Pharmacogenomics J
; 18(4): 556-564, 2018 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29282362
10.
Epidermolysis bullosa acquisita induced by atezolizumab.
J Dtsch Dermatol Ges
; 21(11): 1407-1409, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37658659
11.
Epidermolysis bullosa acquisita ausgelöst durch Atezolizumab.
J Dtsch Dermatol Ges
; 21(11): 1407-1409, 2023 11.
Artigo
Alemão
| MEDLINE | ID: mdl-37946658
12.
Treatment modalities for advanced ALK-rearranged non-small-cell lung cancer.
Future Oncol
; 12(7): 945-61, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26892300
13.
Potential Role of Circulating PD-L1+ Leukocytes as a Predictor of Response to Anti-PD-(L)1 Therapy in NSCLC Patients.
Biomedicines
; 12(5)2024 Apr 25.
Artigo
Inglês
| MEDLINE | ID: mdl-38790920
14.
Kinetics of IFNγ-Induced Cytokines and Development of Immune-Related Adverse Events in Patients Receiving PD-(L)1 Inhibitors.
Cancers (Basel)
; 16(9)2024 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38730712
15.
Difficulties on the access to innovative targeted therapies for lung cancer in Spain.
Clin Transl Oncol
; 26(3): 597-612, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-37651020
16.
EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers.
NPJ Precis Oncol
; 8(1): 37, 2024 Feb 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38366021
17.
Lytic lesions in a patient with past history of renal cancer.
Arch Esp Urol
; 66(3): 302-4, 2013 Apr.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-23648750
18.
SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022).
Clin Transl Oncol
; 25(9): 2679-2691, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37418123
19.
Cost-effectiveness of adjuvant atezolizumab versus best supportive care in the treatment of patients with resectable early-stage non-small cell lung cancer and overexpression of PD-L1.
J Med Econ
; 26(1): 445-453, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36883193
20.
Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05).
J Clin Oncol
; 41(28): 4478-4485, 2023 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37603816